Patents by Inventor Karl Scheidt

Karl Scheidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9260564
    Abstract: A cooperative catalyst system includes a Lewis acid and a Lewis base for the formation of non-isocyanate based polyurethane using a cyclic carbonate and an amine. A method of forming non-isocyanate based polyurethane includes providing a cyclic carbonate, an amine, and a cooperative catalyst system that has a Lewis acid and a Lewis base.
    Type: Grant
    Filed: March 2, 2015
    Date of Patent: February 16, 2016
    Assignees: Dow Global Technologies LLC, Northwestern University
    Inventors: Vincent Lombardo, Karl Scheidt, Emily Leitsch, John Torkelson, Elizabeth Dhulst, William H. Heath, Nathan Wilmot
  • Publication number: 20150247004
    Abstract: A cooperative catalyst system includes a Lewis acid and a Lewis base for the formation of non-isocyanate based polyurethane using a cyclic carbonate and an amine. A method of forming non-isocyanate based polyurethane includes providing a cyclic carbonate, an amine, and a cooperative catalyst system that has a Lewis acid and a Lewis base.
    Type: Application
    Filed: March 2, 2015
    Publication date: September 3, 2015
    Inventors: Vincent Lombardo, Karl Scheidt, Emily Leitsch, John Torkelson, Elizabeth Dhulst, William H. Heath, Nathan Wilmot
  • Publication number: 20110117649
    Abstract: Various chromanone, flavanone and abyssinone compounds as can be prepared enantioselectively using a chiral thiourea catalyst.
    Type: Application
    Filed: December 13, 2010
    Publication date: May 19, 2011
    Inventors: Karl Scheidt, Margaret Marie Biddle
  • Patent number: 7851640
    Abstract: Various chromanone, flavanone and abyssinone compounds as can be prepared enantioselectively using a chiral thiourea catalyst.
    Type: Grant
    Filed: March 2, 2009
    Date of Patent: December 14, 2010
    Assignee: Northwestern University
    Inventors: Karl Scheidt, Margaret Marie Biddle
  • Publication number: 20090259055
    Abstract: Various chromanone, flavanone and abyssinone compounds as can be prepared enantioselectively using a chiral thiourea catalyst.
    Type: Application
    Filed: March 2, 2009
    Publication date: October 15, 2009
    Inventors: Karl Scheidt, Margaret Biddle
  • Publication number: 20070179597
    Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
    Type: Application
    Filed: April 17, 2007
    Publication date: August 2, 2007
    Inventors: Luis Davila, David Lentz, Gerard Llanos, Jorge Mendez, Pallassana Narayanan, Alan Pelton, Mark Roller, Karl Scheidt, Angelo Scopelianos, William Shaw, James Silver, John Spaltro, Christine Trepanier, David Wilson
  • Publication number: 20070179595
    Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
    Type: Application
    Filed: April 17, 2007
    Publication date: August 2, 2007
    Inventors: Luis Davila, David Lentz, Gerard Llanos, Jorge Mendez, Pallassana Narayanan, Alan Pelton, Mark Roller, Karl Scheidt, Angelo Scopelianos, William Shaw, James Silver, John Spaltro, Christine Trepanier, David Wilson
  • Publication number: 20070179596
    Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
    Type: Application
    Filed: April 17, 2007
    Publication date: August 2, 2007
    Inventors: Luis Davila, David Lentz, Gerard Llanos, Jorge Mendez, Pallassana Narayanan, Alan Pelton, Mark Roller, Karl Scheidt, Angelo Scopelianos, William Shaw, James Silver, John Spaltro, Christine Trepanier, David Wilson
  • Publication number: 20060222756
    Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.
    Type: Application
    Filed: May 19, 2006
    Publication date: October 5, 2006
    Applicant: Cordis Corporation
    Inventors: Luis Davila, David Lentz, Gerard Llanos, Jorge Mendez, Pallassana Narayanan, Alan Pelton, Mark Roller, Karl Scheidt, Angelo Scopelianos, William Shaw, James Silver, John Spaltro, Christine Trepanier, David Wilson